Global Interventional Cardiology Devices Market is anticipated to observe an impressive growth during the forecast period, 2024-2028. The market owes its growth to the factors like increasing number of heart related diseases that are life threatening as well as the technological advancements in the medical devices that are launched in this field.
The interventional cardiology devices are the tools that are used to perform surgical and diagnostic procedures that are required for the cardiovascular diseases specifically. Additionally, these procedures ensure recovery that is quick and efficient thereby supporting the market growth in the upcoming future. The availability of the various product that are specific to the various procedures for the diagnostics and the surgical procedures is driving the growth of the global interventional cardiovascular devices market in the forecast period.
Increasing Prevalence of Non-Communicable Diseases
According to the WHO statistics, around 41 million people are killed each year suffering from Non-Communicable Diseases (NCD), out of which 17 million people die from NCD at the age below 70 years.
Growing Demand for Minimally Invasive Surgeries
Minimally invasive surgeries are surgeries performed with minimal invasion and are associated with reduced pain, lesser complications, and quicker recovery. Minimally invasive surgeries are best undergone various changes in techniques beneficial to the patient requiring a surgery. Minimally invasive surgeries are surgeries which can be done to treat several heart conditions, by offering minimal incision performed to reach the heart for initiating treatment and is highly recommended as it causes comparably less pain and quick recoveries than the other cardiac surgeries. These minimally invasive surgeries have huge advantage of lesser traumas in the patients going through these procedures. Several type of heart procedures are performed through minimally invasive surgeries such as Aortic valve replacement, Coronary artery bypass surgeries, Mitral valve repair or replacement, or atrioventricular septal defect surgery, etc. and therefore is aiding the patients with cardiovascular diseases. exposure to minimally invasive surgeries in both the diagnostic and treatment surgeries. The minimally invasive surgeries offer advantages over open heart surgeries such as less blood loss, reduced pain, smaller noticeable scars, lower infection risk, etc.
Minimally invasive surgeries demand smaller incisions than other traditional open-heart surgeries, which means that there is less scarring, reduced blood loss, and a quick recovery time. Patients also experience less pain and discomfort after the procedure, reducing the need for strong pain medications. Including minimally invasive surgeries, there is a reduced risk of infection because the incisions are minor, and there is a lesser exposure of the surgical site to external contaminants. Also, compared to the traditional open-heart surgeries, the minimally invasive surgeries have a shorter recovery time, allowing patients to return to their normal activities sooner.
Growing Sedentary Lifestyle and Increasing Obesity Cases
According to Centre for Disease Control and Prevention, in 2020, the US prevalence of obesity was 39.8% among adults aged 20 to 39 years, 44.3% among adults aged 40 to 59 years, and 41.5% among adults aged 60 and older.
The leading cause of obesity that takes to cardiovascular disease is by causing disturbances s body’s metabolism and therefore leading to a condition such as stroke and other chronic inflammation. Excess body fat can increase the production of pro-inflammatory molecules, which can damage the lining of blood vessels and lead to the development of atherosclerosis. Obesity can also increase the risk of developing hypertension or high blood pressure, another significant risk factor for cardiovascular disease. When excess body fat is present, the body requires more blood to supply nutrients and oxygen to the tissue, which can cause an increase in blood pressure , which over time can damage blood vessels, increasing the risk of developing heart disease. Atherosclerosis is a condition in which the arteries become narrow and stiff, making it harder for blood to flow through them. This can lead to heart attacks, strokes, and other cardiovascular problems.
Recent Development
In 2022, the major technology, diagnostic and digital solutions innovator GE Healthcare collaborates with Boston Scientific- a major medical device manufacturer leader, to strengthen the potential of interventional cardiology and to offer advanced heart care in India.
Download Free Sample Report
Market Segmentation
The global interventional cardiovascular devices market is segmented by product type, end user, regional distribution, and competitive landscape. Based on the product type, the market is segmented into, angioplasty balloons, angioplasty stents, structural heart devices, catheters, plaque modification devices, hemodynamic flow alteration devices, others. Depending on the end users, the market is grouped into hospitals & clinics, ambulatory surgery centers, and others.
Market Players
Medtronic Plc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edward LifeSciences Corporation, Cardinal Health, Inc., iVascular - Dispositivos Cardiovasculares, B. Braun Melsungen AG, Terumo Corporation, Biosensors International Group Ltd. are some of the key players operating in the market.
Attribute | Details |
Base Year | 2022 |
Historical Years | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | · Product Type · End User |
Regional Scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
Country Scope | United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait |
Key Companies Profiled | Medtronic Plc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik, Inc., Edward LifeSciences Corporation, Cardinal Health, Inc., iVascular - Dispositivos Cardiovasculares, B. Braun Melsungen AG, Terumo Corporation, Biosensors International Group Ltd, Cordis Corporation, Cook Medical Inc., C. R. Bard, Inc, MicroPort Scientific Corporation, Stentys SA |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |